{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3],[15,2,15,3],[19,2,19,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910459909603321"]
[null,null,"Titolo",null,"Guidelines for the treatment of malaria [[electronic resource] /] / World Health Organization"]
[null,null,"Pubbl/distr/stampa",null,"Geneva, : World Health Organization, c2010"]
[null,null,"ISBN",null,"1-282-76086-6"]
[{"$nulls":4},"9786612760860"]
[{"$nulls":4},"92-4-068540-5"]
[null,null,"Edizione",null,"[2nd ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (207 p.)"]
[null,null,"Collana",null,"Nonseral Publication"]
[null,null,"Disciplina",null,"616.9362"]
[null,null,"Soggetti",null,"Malaria - Chemotherapy"]
[{"$nulls":4},"Antimalarials"]
[{"$nulls":4},"Malaria - Diagnosis"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Executive summary contains : 1. Reccomendations unchanged from the first edition of the Guidelines (2006) and 2. Additional recommendations in the second edition of the Guidelines (2010)."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"COVER; TITLE; COPYRIGHT; Contents; GLOSSARY; ABBREVIATIONS; EXECUTIVE SUMMARY; 1. INTRODUCTION; 2. CLINICAL DISEASE AND EPIDEMIOLOGY; 3. OBJECTIVES OF TREATMENT; 4. RESISTANCE TO ANTIMALARIAL MEDICINES; 5. ANTIMALARIAL TREATMENT POLICY; 6. DIAGNOSIS OF MALARIA; 7. TREATMENT OF UNCOMPLICATED P. FALCIPARUM MALARIA; 8. TREATMENT OF SEVERE P. FALCIPARUM MALARIA; 9. TREATMENT OF MALARIA CAUSED BY P. VIVAX, P. OVALE OR P. MALARIAE; 11. COMPLEX EMERGENCIES AND EPIDEMICS; 12. CASE MANAGEMENT IN THE CONTEXTOF MALARIA ELIMINATION; 13. MASS DRUG ADMINISTRATION; LIST OF ANNEXES; INDEX"]
[null,null,null,"Sommario/riassunto","Malaria control requires an integrated approach, including prevention (primarily vector control) and prompt treatment with effective antimalarials. Since the publication of the first edition of these Guidelinesin 2006, most of the countries where P. Falciparum is endemic have progressively updated treatment policies from the failing chloroquine and sulphadoxine-pyrimethamine to the recommended artemisinin-based combination therapies (ACTs); this is the best current treatment for uncomplicated falciparum malaria. Unfortunately, the implementation of these policies has lagged behind due to vario"]